Article thumbnail

Gingyo-San Enhances Immunity and Potentiates Infectious Bursal Disease Vaccination

By Che-Ming Hung, Chia-Chou Yeh, Kowit-Yu Chong, Hsiao-Ling Chen, Jiun-Yu Chen, Shung-Te Kao, Chih-Ching Yen, Ming-Hsien Yeh, Maw-Sun Lin and Chuan-Mu Chen

Abstract

The purpose of the present study was to investigate the effects of Gingyo-san (GGS), a traditional Chinese medical formula, on peripheral lymphocyte proliferation and serum antibody titers in chickens vaccinated against the infectious bursal disease (IBD) virus. Treatment groups were fed one of three doses of GGS in their diet (0.5%, 1.0% and 2.0%, w/w), and the IBD vaccine was administered at 1 and 3 weeks of age. At Weeks 8, 12 and 16, changes in serum IBD antibody titers were measured via the micro-method and T cell proliferation. In gene expression experiments, GGS-treated peripheral T lymphocytes were stimulated with concanavalin A (ConA) for 24 h. The mRNA expression of interleukin-2 (IL-2), interferon-γ (IFN-γ), interleukin-4 (IL-4) and interleukin-12 (IL-12) was determined using a semi-quantitative RT-PCR assay. The results showed that a low dose of GGS could significantly raise the antibody titers. Medium and high doses of GGS enhanced IL-2 and IFN-γ production. GGS altered the expression of IL-4 and IL-12 in T lymphocytes. CD4+ T lymphocyte development was also skewed towards the Th1 phenotype. GGS enhanced cell-mediated immunity and augmented the effects of IBD vaccination in strengthening subsequent anti-viral responses

Topics: Original Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3095499
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2003). A comparative study on the pharmacodynamic effects of different preparations of yinqiao powder on bacteria and viruses,”
  2. (2008). An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003: a randomized, double-blind, and controlled pilot study,” Evidence-Based Complementary and Alternative Medicine,v o l .5 ,n o .3 ,p p .
  3. (1998). Antipyretic activity of Gingyo-san, a traditional medicine,
  4. (1999). Antiviral effect of gingyo-san, a traditional chinese herbal medicine, on influenza A2 virus infection in mice,”
  5. (2008). C h e n ,J .Y .H u a n g
  6. Clinical application and pharmacological experiment study of yingqiao powder,”
  7. (2005). Comparative study on adjuvanticity of compound Chinese herbal medicinal ingredients,”
  8. (2000). Effect of ascorbic acid supplementation on the immune response of chickens vaccinated and challenged with infectious bursal disease virus,”
  9. (2004). Effects of Chinese herbal medicinal ingredients on peripheral lymphocyte proliferation and serum antibody titer after vaccination in chicken,”
  10. (2005). Enhanced immunopathology induced by very virulent infectious bursal disease virus,”
  11. (2004). Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2,” Virology,
  12. (2008). Expression of VP1 protein in the milk of transgenic mice: as a potential oral vaccine protects againstenterovirus71infection,”
  13. (2000). Growth enhancement of fowls by dietary administrationofrecombinantyeastculturescontainingenrichedgrowth hormone,”
  14. (2006). I.Eldaghayes,L.Rothwell,A.Williamsetal.,“Infectiousbursal disease virus: strains that differ in virulence differentially modulate the innate immune response to infection in the chicken bursa,”
  15. (1999). Ig transport and the polymeric immunoglobulin receptor,” in Mucosal Immunology,P
  16. (2003). Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species,” Planta Medica,v o l .6 9 ,n o .7 ,p p .
  17. (1998). Infectious bursal disease and hemorrhagic enteritis,”
  18. (1997). Infectious bursal disease virus: a review of molecular basis for variations in antigenicity and virulence,”
  19. (1998). L e e ,Y .S u e n ,J .Q i a n ,E .K n o p p e l ,a n dM .S .C a i r o ,“ T h e regulation and biological activity of interleukin 12,” Leukemia and Lymphoma,
  20. (2006). L-Arginine stimulates intestinal intraepithelial lymphocyte functions and immune response in chickens orally immunized with live intermediate plus strain of infectious bursal disease vaccine,”
  21. (2003). Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes,”
  22. (2001). Molecular characteristics of full-length of genomic segment A of three infectious bursal disease viruses in China: two attenuated and a field virulent strain,”
  23. (1998). Poultry industry strategies for control of immunosuppressive diseases,”
  24. (2006). Production and characterization of human extracellular superoxide dismutase in the methylotrophic yeast Pichia pastoris,”
  25. (2004). Production of recombinant porcine lactoferrin exhibiting antibacterial activity in methylotrophic yeast,
  26. (2007). Protective and immunomodulatory effect of Gingyo-san in a murine model of acute lung inflammation,”
  27. (2006). R.D.Miles,G.D.Butcher,P.R.Henry,andR.C.Littell,“Effect of antibiotic growth promoters on broiler performance, intestinal growth parameters, and quantitative morphology,”
  28. (2007). Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance,”
  29. (1999). Retinoids synergize with interleukin-2 to augment IFN-γ and interleukin-12 production by human peripheral blood mononuclear cells,”
  30. (2002). Role of intrabursal T cells in infectious bursal disease virus (IBDV) infection: T cells promote viral clearance but delay follicular recovery,”
  31. (2001). S.-T.Kao,C.-C.Yeh,C.-C.Hsiehetal.,“TheChinesemedicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest,”
  32. (1983). Studies in immunization of infectious bursal disease,”
  33. (2001). Studies on antiviral flavonoids in yinqiaosan powder,”
  34. (2005). T helper cell fate specified by kinase-mediated interaction
  35. (1996). Target-induced inactivation and cell death by apoptosis in a subset of human
  36. (2002). Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine α-lactalbumin regulation sequences,”
  37. (2002). The effects of gamma interferon on replication of foot-andmouth disease virus in persistently infected bovine cells,”
  38. (2003). The mosaic of immunosuppressive drugs,”